About MiMedx Group, Inc.

MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx Group was founded on July 30, 1985 and is headquartered in Marietta, GA.

At the moment the company generates 303M USD in revenues.

On its last earning announcement, the company reported a profit of 0.31$ per share.

The book value per share is 1.28$

MiMedx Group, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
303M 88.10% 31M 10.19% 35M 0.31 - - 116M 1.28 59M -5M 53M